Posted on 18 November 2014
Baring Private Equity Asia said on Monday it has agreed to buy Japanese drugmaker Bushu Pharmaceuticals, valued at 77.3 billion yen ($668 million), from Tokio Marine Capital.
Bushu is a leading pharmaceutical contract manufacturing organisation (CMO) in Japan.
For further deal information visit Current Agreements (subscription required)
Report: Top 50 Big Pharma Partnering and M&A Deal Trends
Report: Top 50 Big Biotech Partnering and M&A Deal Trends
Browse: Complete Current Partnering report catalog